Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04788264 · ClinicalTrials.gov registry record · NA

Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment

A NA study of Head and Neck Carcinoma and Oropharyngeal Carcinoma, sponsored by Thomas Jefferson University.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT04788264: Completed NA study of Head and Neck Carcinoma and Oropharyngeal Carcinoma, sponsored by Thomas Jefferson University.

NCT04788264 is a NA study of Head and Neck Carcinoma and Oropharyngeal Carcinoma that has completed, run by Thomas Jefferson University. The registered enrollment target is 12 participants, below the 413-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04788264, a NA study of Head and Neck Carcinoma and Oropharyngeal Carcinoma, has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This clinical trial evaluates the tolerability of a physical activity program in head and neck cancer patients who are undergoing cancer treatment. The goal of this trial is to give patients exercises prescribed by a physical therapist that they are able to complete regularly at home. Increasing physical activity may help patients reduce fatigue, improve mood, increase physical performance, and decrease joint pain.

Primary Outcome

Changes in physical activity of the intervention group at 6-weeks and 12-weeks, compared to baseline, using two-sample t-tests, respectively. Longitudinal models such as (non)linear mixed models or generalized estimating equation (GEE) models

Interventions

  • OTHER Questionnaire Administration
  • OTHER Exercise Intervention
  • OTHER Medical Device Usage and Evaluation
  • BEHAVIORAL Behavioral Intervention
  • OTHER Consultation

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2021-03-28
Est. Completion 2023-06-29
Phase NA
Thomas Jefferson University

292 total trials

What the finished NCT04788264 record still lists

NCT04788264 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 413-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (97% lower).

The record links to 10 conditions, with Head and Neck Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.

NCT04788264 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04788264 about?

NCT04788264 is a clinical study titled "Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment". This clinical trial evaluates the tolerability of a physical activity program in head and neck cancer patients who are undergoing cancer treatment. The goal of this trial is to give patients exercises prescribed by a physical therapist that they are able to complete regularly at home. Increasing phy...

What is the current status of trial NCT04788264?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-03-28. Estimated completion is 2023-06-29.

What conditions does trial NCT04788264 study?

This clinical trial studies the following conditions: Head and Neck Carcinoma, Oropharyngeal Carcinoma, Oral Cavity Carcinoma, Stage II Laryngeal Cancer AJCC v8, Laryngeal Carcinoma.

What interventions are being tested in trial NCT04788264?

The interventions under investigation include: Questionnaire Administration (OTHER), Exercise Intervention (OTHER), Medical Device Usage and Evaluation (OTHER), Behavioral Intervention (BEHAVIORAL), Consultation (OTHER).

Who is sponsoring clinical trial NCT04788264?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04788264 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04788264's enrollment target sits among peer trials

12 28th of 30 higher than 2 of 30 other Head and Neck Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04788264, the US trial registry maintained by the National Library of Medicine. NCT04788264 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.